1. The use of organs from animal donors (xenotransplantation) is a pot
ential solution tal the chronic shortage of allogeneic organs and curr
ently the pig is thought to be the most suitable donor for man, Howeve
r, porcine organs are rejected rapidly by a vascular process called hy
peracute rejection which has so far prevented clinical xenotransplanta
tion, Although it is likely that this barrier will be overcome in the
near future by the application of novel strategies, probably involving
the use of organs from transgenic pigs, data from animal models indic
ate that multiple other immune mechanisms will contribute to the rejec
tion of xenografts, 2, We have described two aspects of these immune m
echanisms, First, the phenomenon of 'accommodation', whereby xenograft
s acquire in vivo resistance to vascular rejection, has been explored
in an in vitro model utilizing immortalized porcine endothelial cells.
The results indicate that human anti-pig antibodies induce a concentr
ation-dependent and time-dependent change in porcine endothelial cells
compatible with the development of accommodation. 3, Secondly, the in
vitro human anti-porcine T-cell response has been documented in detai
l, with particular emphasis on quantitative and qualitative comparison
s with the in vitro T-cell alloresponse. The results of this work, whi
ch indicate that the response to porcine xenografts is likely to be si
gnificantly stronger than that against allografts, have important impl
ications for the level of conventional immunosuppression that may be n
ecessary to prevent xenograft rejection, and provide an important basi
s for the development of strategies to promote xenograft-specific immu
nosuppression and tolerance.